International Flavors & Fragrances Inc
Materials
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
520 / 631
Position in country
11426 / 14179
Return on Assets, %
-8
2.5
Net income margin, %
-96.6
4.2
EBITDA margin, %
14
11
Debt to Equity, %
68.9
30
Intangible assets and goodwill, %
61.3
2.6
Revenue CAGR 3Y, %
31.1
10
Total Equity change 1Y, %
-17.3
-0.3
Revenue Y, % chg
-7.8
-7.8
P/BV
1.4
1.6
P/S
1.8
1.7
EV/S
2.6
1.8
EV/EBITDA
14.3
13
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
4.6
24.8
Forward P/E
22
17.1
Dividend Yield, %
1.9
1.6
Forward Dividend Yield, %
1.9
0.2
Expected dividend per share
1.6
0.1
Dividend Ex Date
2024-03-21
Competitors
Ranks
-
Livent Corp
00%
-
RPM International Inc
00%
-
Sherwin-Williams Co
00%
-
PPG Industries Inc
00%
-
Celanese Corp
00%
-
Eastman Chemical Co
00%
-
Ecolab Inc
00%
-
Albemarle Corp
00%
-
Dupont De Nemours Inc
00%
-
International Flavors & Fragrances Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Materials
Industry group
Materials
Industry
Chemicals
Sub-sector
Materials
Capitalization (millions of $)
21347.2
Ticker
IFF.N
ISIN
US4595061015
IPO date
1964-03-02
Availability on Russian exchanges
Yes
Reporting for
2024-02-28
Date fact. publication of reports
2023-12-31
Company Description
International Flavors & Fragrances Inc. offers sensory, food and beverage, pharmaceutical, health and wellness, home and personal care solutions and ingredients. It operates through segments such as Nourish, Scent, Health & Biosciences, and Pharma Solutions. The Nourish segment consists portfolio of natural-based ingredients to improve nutritional value, texture and functionality in a range of beverage, dairy, bakery, confectionery and culinary applications. The Scent segment consists of its legacy Scent segment as well as its Flavor Ingredients business. The Health & Biosciences segment includes a biotechnology-driven probiotics portfolio, that produces cultures for use in fermented foods such as yogurt, cheese and fermented beverages. The Pharma Solutions segment consists of cellulosics and alginates-based pharma excipients.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: